FY2026 · ended Jun 30, 2026 · Revenue $989.71M, +15.9% YoY · Filed Sep 9, 2026
InnovAge Holding Corp. (INNV) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $989.7 million and a net loss of $2.5 million. Free cash flow was $50.4 million. As of Sep 30, 2026 it held $163.0 million in cash and investments and $83.9 million in total debt.
Revenue (TTM)
$1.02B
+15.1% vs year-ago TTM
Net income (TTM)
$9.00M
+151.8% vs year-ago TTM
Operating cash flow (TTM)
$89.53M
+102.1% vs year-ago TTM
Free cash flow (TTM)
$76.31M
+111.0% vs year-ago TTM
EPS (TTM)
$0.07
+151.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
136.45M
+0.6% vs prior year
Net cash
$79.06M
as of Sep 30, 2026
Operating margin
1.4%
FY 2027
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- INNV (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Denver, CO
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1834376
- Former names
- TCO GROUP HOLDINGS, INC. (until Jan 20, 2021)
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- U S Physical Therapy Inc /NV USPH
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $989.7M | $853.7M | $763.9M | $688.1M | $698.6M |
| Operating income | $2.6M | -$29.8M | -$23.2M | -$49.4M | -$4.4M |
| Net income | -$2.5M | -$30.3M | -$21.3M | -$40.7M | -$6.5M |
| Diluted EPS | -$0.02 | -$0.22 | -$0.16 | -$0.30 | -$0.05 |
| Operating cash flow | $64.7M | $32.9M | -$36.9M | $20.2M | $27.3M |
| Free cash flow | $50.4M | $26.6M | -$44.8M | -$3.1M | -$10.9M |
| Total assets | $557.4M | $526.9M | $547.7M | $567.4M | $555.6M |
| Total liabilities | $288.6M | $263.9M | $247.9M | $252.6M | $201.9M |
| Stockholders' equity | $235.6M | $235.0M | $269.3M | $296.3M | $332.4M |
| Cash and investments | $141.3M | $105.9M | $105.4M | $179.0M | $189.9M |
| Total debt | $87.7M | $101.4M | $113.8M | $110.0M | $86.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| ARS | Annual report to shareholders | Oct 22, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 24, 2026 | Sep 22, 2026 |
| 10-K | Annual report | Sep 9, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 8, 2026 | Sep 8, 2026 |
All 271 InnovAge Holding Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.